Awakn Life Sciences (Awakn Life Sciences) Long-Term Capital Lease Obligation : $0.00 Mil (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Awakn Life Sciences Long-Term Capital Lease Obligation?

Awakn Life Sciences's Long-Term Capital Lease Obligation for the quarter that ended in Jan. 2024 was $0.00 Mil.

Awakn Life Sciences's annual Long-Term Capital Lease Obligation declined from Jan. 2022 ($1.15 Mil) to Jan. 2023 ($0.92 Mil) and declined from Jan. 2023 ($0.92 Mil) to Jan. 2024 ($0.00 Mil).

Awakn Life Sciences Long-Term Capital Lease Obligation Historical Data

The historical data trend for Awakn Life Sciences's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Long-Term Capital Lease Obligation Chart

Awakn Life Sciences Annual Data

Trend

Jan21

Jan22

Jan23

Jan24

Long-Term Capital Lease Obligation

0.09

1.15

0.92

Awakn Life Sciences Quarterly Data
	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial								0.92	1.00	-	-	-

Awakn Life Sciences (OTCPK:AWKNF) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Awakn Life Sciences Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Awakn Life Sciences (Awakn Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

954:Germany AWKN:Canada

Address

301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2

Website

https://www.awaknlifesciences.com

Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines

From GuruFocus

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By GuruFocusNews GuruFocusNews • 06-21-2022

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By PurpleRose PurpleRose • 07-11-2022

CEO Presenting on the Emerging Growth Conference on June 22 Register Now

By GuruFocusNews GuruFocusNews • 07-01-2022

KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th

By PRNewswire PRNewswire • 10-11-2021